Crystalline forms of pyrroloquinoline quinone disodium salt

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9695164
APP PUB NO 20150291583A1
SERIAL NO

14441571

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to crystalline forms of pyrroloquinoline quinone disodium salt. The present invention provides crystalline Form A and crystalline Form B of pyrroloquinoline quinone disodium salt, and the methods and uses for the preparation thereof. The X-ray powder diffraction patterns of crystalline Form A and crystalline Form B are as shown by FIG. 1 and FIG. 5, respectively. The crystalline forms of the present invention have low moisture absorption and high stability, as well as excellent use and storage performances.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ZHUCHENG HAOTIAN PHARM CO LTD262218 XINXING TOWN ZHUCHENG CITY WEIFANG CITY SHANDONG PROVINCE WEIFANG CITY SHANDONG PROVINCE 262218

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gu, Jianxin Shanghai, CN 51 550
Lu, Liye Shanghai, CN 3 1
Mei, Xuefeng Shanghai, CN 16 18
Sun, Linlin Shanghai, CN 8 12
Wang, Jianrong Shanghai, CN 26 258
Zhu, Liping Shandong, CN 20 319

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 4, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00